Perrigo reported $0.8 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.79 0.36 Feb/26 2026
FY2025Q3 Sep/2025 0.80 0.76 0.81 Nov/05 2025
FY2025Q2 Jun/2025 0.57 0.59 0.53 Aug/06 2025
FY2025Q1 Mar/2025 0.60 0.48 0.29 May/07 2025
FY2024Q4 Dec/2024 0.36 0.95 0.86 Feb/27 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Abbott USD 1.5 0.2 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Corcept Therapeutics USD 0.16 0.13 Sep/2025
Dr.Reddys Laboratories INR 14.52 2.98 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nestle CHF 2.09 0.15 Jun/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Prestige Brands USD 1.07 0.12 Sep/2025
Reckitt Benckiser GBP 1.41 0.47 Jun/2025
Sanofi EUR 1.53 1.38 Dec/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025
Zoetis USD 1.7 0.06 Sep/2025